← Back to Search

Group Cognitive Behaviour Therapy for Perinatal Anxiety (CBT-PA) for Perinatal Anxiety

N/A
Waitlist Available
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-treatment (intake assessment); immediately post-treatment; 1- and 3-month follow-ups; and weekly during treatment up to 6 weeks
Awards & highlights

Study Summary

This trial is testing whether a specific kind of cognitive behavioral therapy can help reduce symptoms of anxiety and depression for pregnant women and new mothers.

Eligible Conditions
  • Perinatal Anxiety

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-treatment (intake assessment); immediately post-treatment; 1- and 3-month follow-ups; and weekly during treatment up to 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-treatment (intake assessment); immediately post-treatment; 1- and 3-month follow-ups; and weekly during treatment up to 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in scores on the Perceived Stress Scale
Changes in scores on the Perinatal Anxiety Screening Scale
Secondary outcome measures
Change in scores on the Maternal Antenatal Attachment Scale
Change in scores on the Maternal Efficacy Questionnaire
Change in scores on the Maternal Postnatal Attachment Scale
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group CBT for Perinatal AnxietyExperimental Treatment1 Intervention
Using cognitive-behavioural therapy principles, this group therapy is intended to treat perinatal anxiety.
Group II: Waitlist ControlActive Control1 Intervention
This is a control condition in which patients are randomly assigned to the waitlist control condition before receiving the treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Group Cognitive Behaviour Therapy for Perinatal Anxiety (CBT-PA)
2020
N/A
~80

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,450 Total Patients Enrolled
1 Trials studying Perinatal Anxiety
95 Patients Enrolled for Perinatal Anxiety

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been recruited for this clinical trial?

"Affirmative. The clinical trial's details on the website, which first appeared on December 2nd 2020 and was last revised November 14th 2022, indicate that it is now actively seeking participants from one medical centre with a total of 50 patients needed for enrolment."

Answered by AI

What outcomes is the clinical trial hoping to generate?

"This clinical trial is intended to measure changes in scores on the Perinatal Anxiety Screening Scale. Along with this primary objective, there are also secondary objectives which focus on gauging shifts in anxiety severity using the Hamilton Anxiety Rating Scale, evaluating how coronavirus has impacted participants via the Coronavirus Stressor Survey and assessing patient impressions of treatment satisfaction through The Treatment Satisfaction Measure. Data collection will occur pre-treatment; post-treatment; 1-, 3-, and 6 month follow ups as well as weekly during a six week period."

Answered by AI

Is enrollment still underway for this trial?

"According to the information published on clinicaltrials.gov, recruitment for this medical trial is actively ongoing. It was first announced on December 2nd 2020 and its details have been updated as recently as November 14th 2022."

Answered by AI
~17 spots leftby Apr 2025